A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: molecular and functional characterization.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular Genetics and Metabolism

• Publication date

  2012-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ymgme.2012.05.015PMID 22705348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Insights on Pathogenic Effects of Mutations Causing Phosphoglycerate Kinase Deficiency

  2012cited by this paper
• A Spring-loaded Release Mechanism Regulates Domain Movement and Catalysis in Phosphoglycerate Kinase*

  2011cited by this paper
• Enzymatic and metabolic characterization of the phosphoglycerate kinase deficiency associated with chronic hemolytic anemia caused by the PGK-Barcelona mutation.

  2011cited by this paper
• Presenting your structures: the CCP4mg molecular-graphics software

  2011cited by this paper
• Myopathy and parkinsonism in phosphoglycerate kinase deficiency

  2010cited by this paper
• Transition state analogue structures of human phosphoglycerate kinase establish the importance of charge balance in catalysis.

  2010cited by this paper
• Insight into the mechanism of domain movements and their role in enzyme function: example of 3-phosphoglycerate kinase.

  2010cited by this paper
• Substrate binding modifies the hinge bending characteristics of human 3‐phosphoglycerate kinase: A molecular dynamics study

  2009cited by this paper
• Myopathic form of phosphoglycerate kinase (PGK) deficiency: a new case and pathogenic considerations.

  2009cited by this paper
• Communication between the nucleotide site and the main molecular hinge of 3-phosphoglycerate kinase.

  2008cited by this paper
• PGK deficiency

  2007cited by this paper
• Altered expression of PGK1 in a family with phosphoglycerate kinase deficiency

  2007cited by this paper
• L-nucleoside enantiomers as antivirals drugs: a mini-review.

  2006cited by this paper
• Intronic mutation in the PGK1 gene may cause recurrent myoglobinuria by aberrant splicing

  2006cited by this paper
• A Drosophila Temperature-Sensitive Seizure Mutant in Phosphoglycerate Kinase Disrupts ATP Generation and Alters Synaptic Function

  2004cited by this paper
• Effects of 2,3-diphosphoglycerate and other organic phosphate compounds on oxygen affinity and intracellular pH of human erythrocytes

  2004cited by this paper
• Two Proliferation-Related Proteins, TYMS and PGK1, Could Be New Cytotoxic T Lymphocyte-Directed Tumor-Associated Antigens of HLA-A2+ Colon Cancer

  2004cited by this paper
• Regional localization of the phosphoglycerate kinase gene and pseudogene on the human X chromosome and assignment of a related DNA sequence to chromosome 19

  2004cited by this paper
• Regulation of urokinase receptor expression by phosphoglycerate kinase.

  2004cited by this paper
• Secretion of phosphoglycerate kinase from tumour cells is controlled by oxygen-sensing hydroxylases.

  2004cited by this paper
• Phosphorylation of Pyrimidine l-Deoxynucleoside Analog Diphosphates

  2002cited by this paper
• Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase

  2000cited by this paper
• Biochemical and genetic basis of red cell enzyme deficiencies.

  2000cited by this paper
• Phosphoglycerate kinase deficiency in two brothers with McArdle‐like clinical symptoms

  2000cited by this paper
• Phosphoglycerate kinase deficiency: An adult myopathic form with a novel mutation

  2000cited by this paper
• Involvement of a Cellular Glycolytic Enzyme, Phosphoglycerate Kinase, in Sendai Virus Transcription*

  1999cited by this paper
• Anion activation of 3-phosphoglycerate kinase requires domain closure.

  1998cited by this paper
• Modulation of DNA polymerases alpha, delta and epsilon by lactate dehydrogenase and 3-phosphoglycerate kinase.

  1998cited by this paper
• Modulation of DNA polymerases α, δ and ε by lactate dehydrogenase and 3-phosphoglycerate kinase

  1998cited by this paper
• Synergistic effects of substrate-induced conformational changes in phosphoglycerate kinase activation

  1997cited by this paper
• Hematologically important mutations: molecular abnormalities of phosphoglycerate kinase.

  1996cited by this paper
• Identification of new mutations in two phosphoglycerate kinase (PGK) variants expressing different clinical syndromes: PGK Créteil and PGK Amiens.

  1994cited by this paper
• A splice junction mutation in a new myopathic variant of phosphoglycerate kinase deficiency (PGK North Carolina)

  1994cited by this paper
• Functional identity of a primer recognition protein as phosphoglycerate kinase.

  1990cited by this paper
• Human testis-specific PGK gene lacks introns and possesses characteristics of a processed gene

  1987cited by this paper
• Structure of the human phosphoglycerate kinase gene and the intron-mediated evolution and dispersal of the nucleotide-binding domain.

  1985cited by this paper
• The primary cause of hemolysis in enzymopathies of anaerobic glycolysis: a viewpoint.

  1980cited by this paper
• The primary cause of hemolysis in enzymopathies of anaerobic glycolysis: a viewpoint.

  1980cited by this paper
• Sequence, structure and activity of phosphoglycerate kinase: a possible hinge-bending enzyme

  1979cited by this paper
• International Committee for Standardization in Haematology: Recommended Methods for Red‐Cell Enzyme Analysis *

  1977cited by this paper
• Hereditary deficiency of phosphoglycerate kinase: a new variant in erythrocytes and leucocytes, not associated with haemolytic anaemia

  1977cited by this paper
• 2,3-diphosphoglycerate affects enzymes of glucose metabolism in red blood cells.

  1971cited by this paper
• Kinetic studies on the inhibition of glycolytic kinases of human erythrocytes by 2,3-diphosphoglyceric acid.

  1971cited by this paper
• Red cell phosphoglycerate kinase deficiency. A new cause of non-spherocytic hemolytic anemia.

  1968cited by this paper
• Kinetic studies on the reaction catalyzed by phosphoglycerate kinase. II. The kinetic relationships between 3-phosphoglycerate, MgATP2-and activating metal ion.

  1964cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Phosphoglycerate Kinase Can Adopt Topologically Misfolded Forms That Are More Stable Than Its Native State.

  2026cites this paper
• Physical exercise in metabolic myopathies at risk of rhabdomyolysis: a feasible approach or an unavoidable hazard?

  2025cites this paper
• Phosphoglycerate Kinase Can Adopt a Topologically Misfolded Form that is More Stable than its Native State

  2025cites this paper
• Rare red cell enzymopathies in the indian population: A comprehensive review

  2024cites this paper
• Isolated Hemolytic Anemia in Phosphoglycerate Kinase 1 Deficiency Associated with a Novel PGK1:c.746 A > G;p.(Asn249Ser) Variant

  2024cites this paper
• Progress in PGK1 in Prostate Cancer

  2024cites this paper
• Importance of glucose and its metabolism in neurodegenerative disorder, as well as the combination of multiple therapeutic strategies targeting α-synuclein and neuroprotection in the treatment of Parkinson's disease.

  2023cites this paper
• Curriculum vitae et studiorum

  2022cites this paper
• Recognition of a novel variant of phosphoglycerate kinase 1 deficiency PGK1 Galveston (c.472G > C) in a child with hemolytic anemia, neurologic dysfunction and myopathy

  2022cites this paper
• A Mild Clinical Phenotype with Myopathic and Hemolytic Forms of Phosphoglycerate Kinase Deficiency (PGK Osaka): A Case Report and Literature Review

  2022cites this paper
• Hereditary myopathies associated with hematological abnormalities

  2022cites this paper
• Physiological and Proteomic Signatures Reveal Mechanisms of Superior Drought Resilience in Pearl Millet Compared to Wheat

  2021cites this paper
• Toward Development of the Male Pill: A Decade of Potential Non-hormonal Contraceptive Targets

  2020cites this paper
• Phosphoglycerate kinase 1 (PGK1) in cancer: A promising target for diagnosis and therapy.

  2020cites this paper
• Identification of a novel variant in phosphoglycerate kinase-1 (PGK1) in an African-American child (PGK1 Detroit)

  2019cites this paper
• JIMD Reports, Volume 45

  2019cites this paper
• A Hemizygous Deletion Within the PGK1 Gene in Males with PGK1 Deficiency.

  2019cites this paper
• Phosphoglycerate kinase deficiency: A nationwide multicenter retrospective study

  2019cites this paper
• Testis‐specific calcium‐binding protein CBP86‐IV (CABYR) binds with phosphoglycerate kinase 2 in vitro and in vivo experiment

  2019cites this paper
• A Novel Missense Variant Associated with A Splicing Defect in A Myopathic Form of PGK1 Deficiency in The Spanish Population

  2019influential citation
• Anémies hémolytiques dues à des déficits en enzymes érythrocytaires autres que la G6PD

  2019cites this paper
• Myopathies Related to Glycogen Metabolism Disorders

  2018cites this paper
• Level of residual enzyme activity modulates the phenotype in phosphoglycerate kinase deficiency

  2018cites this paper
• Slowly progressive leukodystrophy in an adolescent male with phosphoglycerate kinase deficiency.

  2018cites this paper
• Proteomic Analysis Reveals Proteins Involved in Seed Imbibition under Salt Stress in Rice

  2017influential citation
• A novel PGK1 mutation associated with neurological dysfunction and the absence of episodes of hemolytic anemia or myoglobinuria.

  2017cites this paper
• Rhabdomyolysis: a genetic perspective

  2015cites this paper
• Clinical Severity of PGK1 Deficiency Due To a Novel p.E120K Substitution Is Exacerbated by Co-inheritance of a Subclinical Translocation t(3;14)(q26.33;q12), Disrupting NUBPL Gene.

  2015cites this paper
• Phosphoglycerate kinase deficiency due to a novel mutation (c. 1180A>G) manifesting as chronic hemolytic anemia in a Japanese boy

  2014cites this paper
• Rare hereditary red blood cell enzymopathies associated with hemolytic anemia – pathophysiology, clinical aspects, and laboratory diagnosis

  2014cites this paper
• pH-dependent relationship between thermodynamic and kinetic stability in the denaturation of human phosphoglycerate kinase 1.

  2014cites this paper
• Insights into human phosphoglycerate kinase 1 deficiency as a conformational disease from biochemical, biophysical, and in vitro expression analyses

  2014cites this paper
• Protein Stability, Folding and Misfolding in Human PGK1 Deficiency

  2013influential citation
• The interplay between protein stability and dynamics in conformational diseases: the case of hPGK1 deficiency.

  2013cites this paper
• Structural and energetic basis of protein kinetic destabilization in human phosphoglycerate kinase 1 deficiency.

  2013cites this paper